Hypertension

This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics  and renal denervation therapy. 

Technology | December 27, 2010
December 27, 2010 – The U.S. Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and...
News | December 21, 2010
December 21, 2010 – A once-daily, three-in-one combination blood pressure treatment has been approved in Germany....
News | December 13, 2010
December 13, 2010 – Based on emerging safety information, the pulmonary arterial hypertension (PAH) drug sitaxentan...

The Symplicity Catheter System delivers radio frequency energy from within the renal artery to block conduction in the surrounding renal nerves. This counteracts chronic activation of the sympathetic nervous system.

Feature | December 13, 2010 | Dave Fornell
For patients with severe hypertension that remains uncontrolled despite medical therapy, radiofrequency (RF) energy can...
News | November 22, 2010
November 22, 2010 – Data presented at the American Heart Association’s Scientific Sessions 2010 showed that...
News | October 20, 2010
October 20, 2010 - The U.S. Food and Drug Administration (FDA) approved a new drug to help prevent stroke and blood...
Technology | October 15, 2010
October 15, 2010 – The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application (ANDA...
News | October 07, 2010
October 7, 2010 - Taking medication at night instead of in the morning significantly increases efficacy in keeping...
News | September 29, 2010
September 29, 2010 - Preclinical data of a therapy designed to treat drug-resistant hypertension was presented last...
News | August 30, 2010
August 30, 2010 – According to the results of a late-breaking analysis involving more than 200 000 patients in recent...
News | August 18, 2010
August 18, 2010 - The U.S. Food and Drug Administration (FDA) today proposed to withdraw approval of the drug...
News | July 01, 2010
July 1, 2010 – Clinical results have shown the Rheos System is successful in lowering blood pressure, CVRx Inc....
News | June 21, 2010
June 21, 2010 – Long-term data presented today from Ardian’s Symplicity HTN-1 study demonstrate that the significant...
Technology | June 15, 2010
June 15, 2010 – Health care professionals can now get information on the diagnosis, pathology, and treatment of...

A new formulation of Epoprostenol for Injection is stable at room temperature for up to 24 hours when diluted.

News | April 26, 2010
April 22, 2010 — An improved formulation of epoprostenol for the treatment of primary pulmonary arterial hypertension (...